Achillion Pharmaceuticals

INVESTORS

Press Releases

 
Press Releases
  Date Title View
Sep 2, 2004
NEW HAVEN, Conn. September 2, 2004 —Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging of infectious diseases, today announced the appointment of Michael D. Kishbauch as Chief Executive Officer. Mr. Kishbauch replaces interim CEO, Marios Fotiadis. Ac...
PDF
FirstPrevious
...
26